Ovid Therapeutics annual revenue
2020
2021
2022
2023
2024
2025
Ovid Therapeutics Revenue Growth & History (OVID)
Ovid Therapeutics reported $7.3M in revenue for fiscal 2025, an increase of 1181.27% from the previous fiscal year.
View full Ovid Therapeutics company overviewOvid Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.3M | $6.7M | +1181.27% |
| 2024 | 2024-12-31 | $566,000 | $174,000 | +44.39% |
| 2023 | 2023-12-31 | $392,000 | −$1.1M | −73.91% |
| 2022 | 2022-12-31 | $1.5M | −$206.9M | −99.28% |
| 2021 | 2021-12-31 | $208.4M | $195.8M | +1551.57% |
| 2020 | 2020-12-31 | $12.6M | — | — |
Ovid Therapeutics quarterly revenue
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $733,000 | −$5.5M | −88.31% |
| Q1 2026 | 2026-03-31 | $0 | −$130,000 | −100.00% |
| Q4 2025 | 2025-12-31 | $718,000 | $642,000 | +844.74% |
| Q3 2025 | 2025-09-30 | $132,000 | −$41,000 | −23.70% |
| Q2 2025 | 2025-06-30 | $6.3M | $6.1M | +3611.24% |
| Q1 2025 | 2025-03-31 | $130,000 | −$18,000 | −12.16% |
| Q4 2024 | 2024-12-31 | $76,000 | −$66,000 | −46.48% |
| Q3 2024 | 2024-09-30 | $173,000 | $64,000 | +58.72% |
| Q2 2024 | 2024-06-30 | $169,000 | $94,000 | +125.33% |
| Q1 2024 | 2024-03-31 | $148,000 | $82,000 | +124.24% |
| Q4 2023 | 2023-12-31 | $142,000 | $95,720 | +206.83% |
| Q3 2023 | 2023-09-30 | $109,000 | $97,898 | +881.81% |
| Q2 2023 | 2023-06-30 | $75,000 | $75,000 | — |
| Q1 2023 | 2023-03-31 | $66,000 | −$1.4M | −95.43% |
| Q4 2022 | 2022-12-31 | $46,280 | $46,280 | — |
| Q3 2022 | 2022-09-30 | $11,102 | $11,102 | — |
| Q2 2022 | 2022-06-30 | $0 | $0 | — |
| Q1 2022 | 2022-03-31 | $1.4M | −$206.9M | −99.31% |
| Q4 2021 | 2021-12-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $0 | −$6.9M | −100.00% |
| Q2 2021 | 2021-06-30 | $0 | — | — |
| Q1 2021 | 2021-03-31 | $208.4M | — | — |
| Q3 2020 | 2020-09-30 | $6.9M | — | — |
Ovid Therapeutics revenue growth trends
Over the last five reported fiscal years, revenue declined from $12.6M to $7.3M, a compound annual decline of 10.48%. Ovid Therapeutics's latest reported quarter, Q2 2026, generated $733,000 in revenue, a decrease of 88.31% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Ovid Therapeutics source filings ↗